Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits

Breast cancer and prostate cancer are the most common cancers diagnosed in women and men, respectively, in the UK, and radiotherapy is used extensively in the treatment of both. In vitro data suggest that tumours in the breast and prostate have unique properties that make a hypofractionated radiothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, K.J., Sibson, N.R., Kiltie, A.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2015
Materias:
Overview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465964/
https://www.ncbi.nlm.nih.gov/pubmed/25752244
http://dx.doi.org/10.1016/j.clon.2015.02.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465964/
https://www.ncbi.nlm.nih.gov/pubmed/25752244
http://dx.doi.org/10.1016/j.clon.2015.02.008

Ejemplares similares